Answers are grounded in this paper and cite their sources.
Demonstrates that the TNFRSF1A polymorphism predicts oral mucositis and treatment response in head and neck cancer, suggesting a role in personalized care.
The TNFRSF1A (-135 T>C) polymorphism influences both toxicity and response in HNSCC, with the C allele predisposing to mucositis and the TT genotype predicting favorable outcomes. It represents a potential biomarker for personalized radiotherapy, meriting validation in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Krishnan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: